Schering-Plough And Organon Japanese Subsidiaries To Consolidate Business
This article was originally published in PharmAsia News
Executive Summary
Japanese subsidiaries of Schering-Plough and Organon Bioscience, which merged last November, Schering-Plough K.K. and Organon Japan announced June 17 the companies will consolidate business starting July 1. The new company will have headquarters in Osaka and marketing headquarters in Tokyo. Schering-Plough K.K. has sales of ¥79.3 billion and Organon has sales of ¥21 billion. Schering-Plough President Masao Torii will become president of new company. (Click here for more - Japanese language)
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.